• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Parenteral Drugs (India) Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524689
INE904D01019
-300.6045095
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PDPL
0
10.11
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

NDL Ventures standalone net profit declines 62.50% in the June 2026 quarter
Aug 11,2026
Net profit of NDL Ventures declined 62.50% to Rs 0.09 crore in the quarter ended June 2026 as against Rs 0.24 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.